SUPPORT FOR ANKYLOSING SPONDYLITIS PATIENTS

Motion Text

That this House supports the National Ankylosing Spondylitis Society (NASS) in its work for people with ankylosing spondylitis (AS), a form of inflammatory arthritis which affects around 200,000 people in the UK with symptoms usually starting in early adulthood; notes the NASS drive to raise awareness of this condition, which can have a major impact on quality of life and ability to work; is concerned that many people with AS in the UK do not receive optimum care because of delayed diagnosis and lack of access to appropriate expertise and therapies; welcomes the recent NASS report Looking Ahead, which highlights the barriers to people with AS receiving the best care; and calls on the Government to ensure access to the specialists and treatments necessary to achieve the best possible outcomes for people with AS.